RIPK 1 in Alzheimer's Disease: Research Progress Integrating Pathogenesis on Necroptosis-Related Neuroinflammation, and Potential Therapeutic Strategies. [PDF]
Toklucu ES, Shen S, Wang C, Zhang C.
europepmc +1 more source
Necroptosis in SJS/TEN: <i>RIPK1</i> and <i>RIPK3</i> Expression and Implications for Disease Pathogenesis. [PDF]
Sooranahalli C, Bouchard C, Iqbal O.
europepmc +1 more source
Endothelial Integrin-Linked Kinase (ILK) Deficiency Promotes Endothelial Activation and Cardiovascular Dysfunction via Receptor Interacting Protein Kinase-1 (RIPK1) Enriched-Extracellular Vesicle Signalling. [PDF]
Cook-Calvete A +9 more
europepmc +1 more source
Metastable Protein-Protein Interactions as a Design Principle for PROTACs: Insights from the RIPK1-VHL System. [PDF]
Wu Y +4 more
europepmc +1 more source
Targeting necroptosis: how does exercise protect against metabolic dysfunction-associated fatty liver disease? [PDF]
Song W, Ke Z.
europepmc +1 more source
Regulatory complexity and therapeutic targeting of the necroptosis network. [PDF]
Niu L, Liu F, Zhao Y, Li J, Wang H.
europepmc +1 more source
Inhibition of RIPK1/RIPK3-MLKL inflammatory signaling pathway activation attenuates preterm birth. [PDF]
Bing X +6 more
europepmc +1 more source
Necroptosis and the RIPK1-RIPK3-MLKL pathway in chronic kidney disease: mechanisms, crosstalk, and therapeutic opportunities. [PDF]
Lu J +7 more
europepmc +1 more source
Novel Substituted Tetrahydropyrrolooxazolones as RIPK1 Inhibitors. [PDF]
Rong J, Liang SH.
europepmc +1 more source
Tussilagone mitigates sepsis-induced acute lung injury in mice by suppressing RIPK1 expression. [PDF]
Gu J +5 more
europepmc +1 more source

